Original Investigation
Caring for the Critically Ill Patient
4% Tetrasodium EDTA to Prevent Central Venous Access Device–Associated Complications: A Randomized Clinical Trial
Marlena Ornowska, Jessica Wittmann, Sandra Blitz, et al
JAMA Published Online: May 18, 2026
doi: 10.1001/jama.2026.6025
Key Points
Question Can the use of 4% tetrasodium EDTA locking fluid decrease rates ...
阅读全文